Key Insights

Highlights

Success Rate

83% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 62/100

Termination Rate

10.0%

1 terminated out of 10 trials

Success Rate

83.3%

-3.2% vs benchmark

Late-Stage Pipeline

10%

1 trials in Phase 3/4

Results Transparency

0%

0 of 5 completed with results

Key Signals

83% success

Data Visualizations

Phase Distribution

9Total
Not Applicable (8)
P 3 (1)

Trial Status

Completed5
Active Not Recruiting2
Not Yet Recruiting1
Terminated1
Withdrawn1

Trial Success Rate

83.3%

Benchmark: 86.5%

Based on 5 completed trials

Clinical Trials (10)

Research Network

Activity Timeline